ADPT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $28.35

Capitalizzazione di Mercato (MRQ) $4.51B

P/E (TTM) -70.9

EPS (TTM) $-0.40

Ricavi (TTM) $308M

ROE (TTM) -39.6%

D/E Debito/Patrimonio (MRQ) 0.0

Intervallo 52 sett. $12–$30

ADPT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Adaptive Biotechnologies Corporation - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaLife Sciences Tools & Services dipendenti624 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$277M

2017-12-31 → 2025-12-31

EPS$-0.39

2020-12-31 → 2025-12-31

Flusso di cassa libero$-49M

2019-12-31 → 2025-12-31

Margine netto-20.7%

2019-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	ADPT	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-70.9media 5 anni ≈-14.9	≈-14.9	·	·
P/S (TTM)	14.6media 5 anni ≈9.9	≈9.9	4.6	Sopravvalutato
P/B (MRQ)	31.6media 5 anni ≈5.4	≈5.4	3.5	Sopravvalutato
EV / EBITDA	-77.4media 5 anni ≈-18.1	≈-18.1	·	·
Prezzo / FCF (TTM)	-187.6media 5 anni ≈-17.1	≈-17.1	·	·
Prezzo / Flusso di cassa (TTM)	-214.6media 5 anni ≈-18.9	≈-18.9	·	·
EV / Revenue (EV / Ricavi)	16.0media 5 anni ≈6.4	≈6.4	·	·
EV / FCF	-90.3media 5 anni ≈-22.2	≈-22.2	·	·
Prezzo / Valore contabile tangibile (MRQ)	31.7media 5 anni ≈10.4	≈10.4	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	ADPT	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-12.2%media 5 anni ≈-97.6%	≈-97.6%	6.4%	Debole
EBITDA Margin (Margine EBITDA)	-20.6%media 5 anni ≈-97.6%	≈-97.6%	7.0%	Debole
Pretax Margin (Margine ante imposte)	-21.5%media 5 anni ≈-97.1%	≈-97.1%	5.9%	Debole
Margine di Profitto Netto (TTM)	-20.7%media 5 anni ≈-97.0%	≈-97.0%	2.4%	Debole
ROA (TTM)	-11.2%media 5 anni ≈-22.1%	≈-22.1%	-0.64%	Debole
ROE (TTM)	-39.6%media 5 anni ≈-43.4%	≈-43.4%	-0.84%	Debole
ROIC	-16.3%	·	-1.8%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	ADPT	media 5 anni	Mediana dei peer	Verdetto
Debito / Patrimonio Netto (MRQ)	0.0media 5 anni ≈0.6	≈0.6	0.7	Basso indebitamento
Rapporto corrente (MRQ)	4.8media 5 anni ≈3.9	≈3.9	3.0	Liquidità elevata
Quick Ratio	1.3media 5 anni ≈1.2	≈1.2	2.2	Liquidità elevata
Debito a lungo termine / Patrimonio netto (MRQ)	0.0media 5 anni ≈0.6	≈0.6	0.7	Basso indebitamento
Interest Coverage (Copertura degli interessi)	-4.8media 5 anni ≈-20.6	≈-20.6	3.7	Bassa liquidità

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	ADPT	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	54.8%media 5 anni ≈25.7%	≈25.7%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	14.3%media 5 anni ≈13.2%	≈13.2%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	23.0%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	ADPT	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-0.39media 5 anni ≈$-1.18	≈$-1.18	·	·
Revenue / Share (Ricavi / Azione)	$1.83media 5 anni ≈$1.38	≈$1.38	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-0.30media 5 anni ≈$-0.83	≈$-0.83	·	·
Cash / Share (Liquidità / Azione)	$0.46media 5 anni ≈$0.57	≈$0.57	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	ADPT	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.5media 5 anni ≈0.3	≈0.3	0.5	In linea
Inventory Turnover (Rotazione delle scorte)	7.8media 5 anni ≈5.1	≈5.1	4.0	Di prim'ordine
Receivables Turnover (Rotazione dei crediti)	6.0media 5 anni ≈6.5	≈6.5	6.2	Debole
Revenue / Employee (Ricavi / Dipendente)	≈$443.9K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 51.3%

Prossimo report Nov 03, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 3, 2026	$-0.10	$-0.14	26.7%
31 Marzo 2026		$-0.12	$-0.16	26.5%
31 Dicembre 2025		$-0.09	$-0.18	51.3%
30 Settembre 2025		$0.06	$-0.15	140.2%
30 Giugno 2025		$-0.17	$-0.24	30.2%
31 Marzo 2025		$-0.20	$-0.30	33.0%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 15

Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue	$277M	$179M	$170M	$185M	$154M	$98M	$85M	$56M
Cost of Revenue	$71M	$72M	$76M	$58M	$49M	$23M	$22M	$20M
R&D Expense	$94M	$103M	$122M	$142M	$142M	$116M	$71M	$39M
SG&A Expense	$73M	$73M	$84M	$89M	$75M	$50M	$30M	$20M
Operating Expenses	$334M	$342M	$397M	$385M	$363M	$251M	$163M	$105M
Operating Income	$-57M	$-163M	$-227M	$-200M	$-209M	$-153M	$-78M	$-50M
Interest Expense	$12M	$12M	$14M	$4M	·	·	·	·
Pretax Income	$-59M	$-160M	$-225M	$-200M	$-207M	$-146M	$-69M	·
Income Tax	$0	$0	$0	·	·	·	$0	·
Net Income	$-59M	$-159M	$-225M	$-200M	$-207M	$-146M	$-69M	$-46M
EPS (Basic)	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48	$-1.11	·	·
EPS (Diluted)	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48	$-1.11	·	·
Shares (Basic)	151,721,939	147,101,648	144,383,294	142,515,917	140,354,915	131,216,468	·	·
Shares (Diluted)	151,721,939	147,101,648	144,383,294	142,515,917	140,354,915	131,216,468	·	·
EBITDA	$-57M	$-163M	$-227M	$-200M	$-209M	$-153M	$-78M	·

Stato Patrimoniale 27

Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Cash & Equivalents	$70M	$48M	$65M	$90M	$139M	$123M	$97M	$55M
Receivables	$50M	$42M	$38M	$40M	$17M	$10M	$13M	$5M
Inventory	$10M	$8M	$14M	$14M	$19M	$14M	$9M	$8M
Prepaid Expense	$13M	$11M	$11M	$9M	$13M	$15M	$14M	$3M
Current Assets	$300M	$284M	$410M	$562M	$403M	$727M	$613M	$181M
PP&E (Net)	$34M	$49M	$68M	$83M	$85M	$40M	$60M	$19M
PP&E (Gross)	$130M	$136M	$141M	$138M	$121M	$64M	$78M	$32M
Accum. Depreciation	$96M	$88M	$73M	$54M	$36M	$24M	$18M	$12M
Goodwill	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M
Intangibles	$2M	$3M	$5M	$7M	$9M	$10M	$12M	$14M
Other Non-current Assets	$1M	$2M	$4M	$2M	$875.0K	$598.0K	$784.0K	$186.0K
Total Assets	$513M	$539M	$661M	$857M	$923M	$1.12B	$912M	$333M
Accounts Payable	$6M	$7M	$8M	$8M	$3M	$3M	$4M	$2M
Accrued Liabilities	$8M	$8M	$9M	$12M	$9M	$13M	$4M	$3M
Current Liabilities	$90M	$98M	$88M	$110M	$114M	$105M	$78M	$23M
Capital Leases	$70M	$79M	$89M	$99M	$107M	$104M	·	·
Other Non-current Liabilities	$20.0K	$20.0K	·	·	·	·	$93.0K	·
Total Liabilities	$288M	$337M	$353M	$393M	$319M	$373M	$341M	$30M
Long-term Debt	$131M	$133M	·	·	·	·	·	·
Total Debt	$131M	$133M	$131M	·	·	·	·	·
Common Stock	$15.0K	$14.0K	$14.0K	$14.0K	$14.0K	$14.0K	$12.0K	$1.0K
Paid-in Capital	$1.58B	$1.51B	$1.45B	$1.39B	$1.32B	$1.25B	$936M	$38M
Retained Earnings	$-1.36B	$-1.30B	$-1.14B	$-919M	$-719M	$-512M	$-365M	$-296M
AOCI	$253.0K	$166.0K	$215.0K	$-4M	$-1M	$893.0K	$671.0K	$-107.0K
Stockholders' Equity	$219M	$203M	$308M	$464M	$604M	$743M	$571M	$-258M
Liabilities + Equity	$513M	$539M	$661M	$857M	$923M	$1.12B	$912M	$333M
Shares Outstanding	153,779,418	147,773,744	145,082,271	143,105,002	141,393,865	137,646,896	125,238,142	12,841,536

Flusso di cassa 13

Metrica	2025	2024	2023	2022	2021	2020	2019	2018
D&A	$16M	$17M	$20M	$21M	·	·	·	·
Stock-based Comp	$51M	$54M	$63M	$55M	$43M	$25M	$13M	$11M
Amort. of Intangibles	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Restructuring	·	$2M	·	$2M	·	·	·	·
Operating Cash Flow	$-46M	$-95M	$-156M	$-184M	$-193M	$-150M	$205M	$-32M
CapEx	$3M	$4M	$11M	$16M	$62M	$19M	$11M	$6M
Investing Cash Flow	$38M	$78M	$130M	$3M	$181M	$-117M	$-482M	$736.0K
Stock Issued	·	·	·	·	·	$272M	$321M	·
Net Stock Activity	·	·	·	·	·	$272M	·	·
Financing Cash Flow	$30M	$241.0K	$2M	$132M	$27M	$294M	$320M	$1M
Net Change in Cash	$22M	$-17M	$-24M	$-49M	$16M	$27M	$44M	$-30M
Free Cash Flow	$-49M	$-99M	$-167M	$-200M	$-254M	$-168M	$194M	·
Levered FCF	$-61M	·	·	·	·	·	·	·

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Operating Margin	-20.6%	-90.8%	-133.3%	-108.0%	-135.4%	-155.3%	-92.2%	·
Net Margin	-21.5%	-89.1%	-132.3%	-108.0%	-134.3%	-148.6%	-80.7%	·
Pretax Margin	-21.5%	-89.2%	-132.3%	-108.1%	-134.3%	·	·	·
EBITDA Margin	-20.6%	-90.8%	-133.3%	-108.0%	-135.4%	-155.3%	-92.2%	·
ROA	-11.3%	-26.6%	-29.7%	-22.5%	-20.3%	-14.4%	-11.0%	·
ROE	-28.2%	-62.4%	-58.3%	-37.5%	-30.8%	-23.0%	-11.9%	·
ROIC	-16.3%	·	·	·	·	·	·	·

Liquidità e Solvibilità 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Current Ratio	3.3	2.9	4.7	5.1	3.5	6.9	7.8	·
Quick Ratio	1.3	0.9	1.2	1.2	1.4	1.3	1.4	·
Debt / Equity	0.6	0.7	0.4	·	·	·	·	·
LT Debt / Equity	0.6	0.7	0.4	·	·	·	·	·
Interest Coverage	-4.8	-14.0	-16.5	-47.2	·	·	·	·

Efficienza 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Asset Turnover	0.5	0.3	0.2	0.2	0.2	0.1	0.1	·
Inventory Turnover	7.8	6.3	5.2	3.4	3.0	1.9	2.6	·
Receivables Turnover	6.0	4.5	4.4	6.4	11.2	8.7	9.7	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Book Value / Share	$1.42	$1.37	$2.13	$3.24	$4.27	$5.40	$4.56	·
Revenue / Share	$1.83	$1.22	$1.18	$1.30	·	·	·	·
Cash Flow / Share	$-0.30	$-0.65	$-1.08	$-1.29	·	·	·	·
Cash / Share	$0.46	$0.32	$0.45	$0.63	$0.98	$0.90	$0.77	·
EPS (TTM)	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48	$-1.11	·	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue YoY	54.8%	5.1%	-8.1%	20.1%	56.9%	·	·	·
Revenue CAGR 3Y	14.3%	5.1%	20.1%	·	·	·	·	·
Revenue CAGR 5Y	23.0%	·	·	·	·	·	·	·

Valutazione (TTM) 14

Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue TTM	$277M	$179M	$170M	$185M	$154M	$98M	$85M	·
Net Income TTM	$-59M	$-159M	$-225M	$-200M	$-207M	$-146M	$-69M	·
Market Cap	$2.50B	$886M	$711M	$1.09B	$3.97B	$8.14B	$3.75B	·
Enterprise Value	$2.56B	$971M	$776M	·	·	·	·	·
P/E	-41.6	-5.6	-3.1	-5.5	-19.0	-53.3	·	·
P/S	9.0	5.0	4.2	5.9	25.7	82.7	44.0	·
P/B	11.4	4.4	2.3	2.4	6.6	11.0	6.6	·
P / Tangible Book	25.5	11.0	3.9	3.2	8.3	13.3	·	·
P / Cash Flow	-54.3	-9.3	-4.5	-5.9	-20.6	-54.4	18.2	·
P / FCF	-51.0	-9.0	-4.3	-5.5	-15.6	-48.3	19.3	·
EV / EBITDA	-44.8	-6.0	-3.4	·	·	·	·	·
EV / FCF	-52.3	-9.8	-4.6	·	·	·	·	·
EV / Revenue	9.2	5.4	4.6	·	·	·	·	·
Earnings Yield	-2.4%	-18.0%	-31.8%	-18.3%	-5.3%	-1.9%	·	·

Conto Economico 13

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Revenue	$72M	$71M	$72M	$94M	$59M	$52M	$47M	$46M	$43M	$42M	$46M	$38M	$49M	$38M	$48M	$44M
Cost of Revenue	$20M	$19M	$18M	$18M	$18M	$17M	$18M	$17M	$19M	$18M	$20M	$19M	$18M	$19M	$15M	$13M
R&D Expense	$19M	$24M	$22M	$24M	$24M	$24M	$23M	$24M	$25M	$30M	$29M	$29M	$32M	$33M	$36M	$37M
SG&A Expense	$21M	$21M	$20M	$18M	$18M	$17M	$18M	$17M	$18M	$20M	$21M	$20M	$22M	$21M	$21M	$21M
Operating Expenses	$87M	$90M	$84M	$84M	$84M	$82M	$81M	$79M	$91M	$91M	$117M	$89M	$97M	$95M	$93M	$96M
Operating Income	$-16M	$-19M	$-13M	$10M	$-25M	$-30M	$-34M	$-33M	$-47M	$-49M	$-71M	$-51M	$-48M	$-57M	$-45M	$-53M
Interest Expense	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$653.0K	·
Net Income	$-40M	$-20M	$-14M	$10M	$-26M	$-30M	$-34M	$-32M	$-46M	$-48M	$-69M	$-50M	$-48M	$-58M	$-45M	$-52M
EPS (Basic)	$-0.25	$-0.13	$-0.08	$0.06	$-0.17	$-0.20	$-0.22	$-0.22	$-0.31	$-0.33	$-0.48	$-0.35	$-0.33	$-0.40	$-0.32	$-0.37
EPS (Diluted)	$-0.25	$-0.13	$-0.08	$0.06	$-0.17	$-0.20	$-0.22	$-0.22	$-0.31	$-0.33	$-0.48	$-0.35	$-0.33	$-0.40	$-0.32	$-0.37
Shares (Basic)	159,855,257	155,521,048	·	152,432,307	152,082,284	149,195,028	·	147,516,398	147,414,095	145,787,527	·	144,704,868	144,397,693	143,511,142	142,928,654	142,363,589
Shares (Diluted)	159,855,257	155,521,048	·	163,162,107	152,082,284	149,195,028	·	147,516,398	147,414,095	145,787,527	·	144,704,868	144,397,693	143,511,142	142,928,654	142,363,589
EBITDA	$-16M	$-19M	·	$10M	$-25M	$-30M	·	$-33M	$-47M	$-49M	·	$-51M	$-48M	$-57M	$-45M	$-53M

Stato Patrimoniale 27

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Cash & Equivalents	$170M	$78M	$70M	$55M	$43M	$51M	$48M	$38M	$60M	$71M	·	$89M	$109M	$95M	$218M	$76M
Receivables	$50M	$48M	$50M	$45M	$44M	$44M	$42M	$41M	$36M	$42M	·	$31M	$32M	$31M	$27M	$24M
Inventory	$10M	$11M	$10M	$10M	$8M	$9M	$8M	$12M	$13M	$13M	·	$19M	$19M	$20M	$17M	$19M
Prepaid Expense	$16M	$14M	$13M	$14M	$11M	$11M	$11M	$12M	$11M	$10M	·	$13M	$9M	$10M	$12M	$12M
Current Assets	$421M	$292M	$300M	$281M	$262M	$256M	$284M	$308M	$352M	$374M	·	$435M	$477M	$501M	$564M	$439M
PP&E (Net)	$29M	$31M	$34M	$37M	$41M	$44M	$49M	$51M	$55M	$65M	·	$77M	$79M	$81M	$87M	$87M
PP&E (Gross)	·	·	$130M	·	·	·	$136M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$96M	·	·	·	$88M	·	·	·	·	·	·	·	·	·
Goodwill	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M	·	$119M	$119M	$119M	$119M	$119M
Intangibles	$884.0K	$1M	$2M	$2M	$3M	$3M	$3M	$4M	$4M	$5M	·	$6M	$6M	$6M	$7M	$8M
Other Non-current Assets	$1M	$1M	$1M	$2M	$2M	$2M	$2M	$3M	$3M	$3M	·	$3M	$3M	$2M	$2M	$778.0K
Total Assets	$641M	$506M	$513M	$491M	$497M	$511M	$539M	$559M	$585M	$620M	·	$718M	$765M	$791M	$884M	$807M
Accounts Payable	$5M	$10M	$6M	$10M	$7M	$6M	$7M	$7M	$10M	$12M	·	$4M	$9M	$6M	$4M	$3M
Accrued Liabilities	$11M	$7M	$8M	$7M	$7M	$8M	$8M	$6M	$7M	$8M	·	$10M	$8M	$8M	$11M	$9M
Current Liabilities	$88M	$87M	$90M	$83M	$92M	$88M	$98M	$88M	$88M	$83M	·	$93M	$95M	$90M	$104M	$111M
Capital Leases	$67M	$69M	$70M	$72M	$74M	$76M	$79M	$82M	$84M	$87M	·	$92M	$94M	$96M	$101M	$103M
Other Non-current Liabilities	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	·	·	·	·	·	·	·
Total Liabilities	$490M	$282M	$288M	$286M	$317M	$321M	$337M	$335M	$343M	$346M	·	$356M	$369M	$368M	$396M	$288M
Long-term Debt	$0	$131M	$131M	$132M	$134M	$134M	$133M	·	·	·	·	$130M	·	·	·	·
Total Debt	$0	$131M	·	$132M	$134M	$134M	·	$133M	$132M	$132M	·	$130M	·	·	·	·
Common Stock	$16.0K	$16.0K	$15.0K	$15.0K	$15.0K	$15.0K	$14.0K	$14.0K	$14.0K	$14.0K	·	$14.0K	$14.0K	$14.0K	$14.0K	$14.0K
Paid-in Capital	$1.57B	$1.60B	$1.58B	$1.55B	$1.54B	$1.52B	$1.51B	$1.49B	$1.48B	$1.47B	·	$1.44B	$1.42B	$1.40B	$1.37B	$1.36B
Retained Earnings	$-1.42B	$-1.38B	$-1.36B	$-1.35B	$-1.36B	$-1.33B	$-1.30B	$-1.27B	$-1.24B	$-1.19B	·	$-1.07B	$-1.02B	$-977M	$-879M	$-834M
AOCI	$-212.0K	$-28.0K	$253.0K	$211.0K	$73.0K	$134.0K	$166.0K	$497.0K	$-182.0K	$-106.0K	·	$-250.0K	$-893.0K	$-2M	$-6M	$-6M
Stockholders' Equity	$143M	$216M	$219M	$204M	$180M	$190M	$203M	$224M	$242M	$275M	·	$362M	$396M	$424M	$488M	$518M
Liabilities + Equity	$641M	$506M	$513M	$491M	$497M	$511M	$539M	$559M	$585M	$620M	·	$718M	$765M	$791M	$884M	$807M
Shares Outstanding	159,059,622	159,697,221	153,779,418	152,581,042	152,234,772	151,916,722	147,773,744	147,561,586	147,462,201	147,368,324	·	144,772,751	144,645,118	144,279,969	142,987,127	142,784,868

Flusso di cassa 10

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
D&A	·	$3M	$3M	$4M	$4M	$4M	$4M	$4M	$5M	$5M	$3M	$6M	$6M	$5M	·	·
Stock-based Comp	$11M	$12M	$13M	$13M	$13M	$12M	$13M	$14M	$13M	$14M	$16M	$15M	$17M	$15M	$14M	$14M
Amort. of Intangibles	$423.0K	$419.0K	$429.0K	$428.0K	$423.0K	$419.0K	$428.0K	$428.0K	$424.0K	$423.0K	$429.0K	$428.0K	$423.0K	$419.0K	$428.0K	$423.0K
Restructuring	·	$643.0K	·	·	·	$0	$87.0K	$193.0K	$680.0K	$1M	·	·	·	·	·	·
Operating Cash Flow	$-6M	$-10M	$2M	$-7M	$-12M	$-28M	$-12M	$-27M	$-17M	$-38M	$-27M	$-47M	$-24M	$-59M	$-42M	$-47M
CapEx	$1M	$796.0K	$636.0K	$409.0K	$655.0K	$1M	$80.0K	$344.0K	$2M	$2M	$1M	$3M	$4M	$3M	$5M	$5M
Investing Cash Flow	$-43M	$9M	$-8M	$17M	$3M	$26M	$22M	$5M	$6M	$45M	$3M	$26M	$37M	$63M	$58M	$5M
Financing Cash Flow	$142M	$8M	$22M	$2M	$2M	$5M	$127.0K	$40.0K	$30.0K	$44.0K	$87.0K	$17.0K	$1M	$672.0K	$126M	$4M
Net Change in Cash	$92M	$7M	$15M	$12M	$-7M	$3M	$10M	$-22M	$-11M	$6M	$-24M	$-21M	$15M	$4M	$141M	$-38M
Free Cash Flow	·	$-10M	·	·	·	$-30M	·	·	·	$-40M	·	·	·	$-62M	·	·

Redditività 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Operating Margin	-22.0%	-27.1%	·	10.9%	-42.5%	-56.5%	·	-70.3%	-109.6%	-116.5%	·	-134.4%	-97.7%	-151.9%	-95.0%	-120.2%
Net Margin	-55.6%	-28.3%	·	10.2%	-43.5%	-56.9%	·	-69.1%	-107.0%	-113.5%	·	-132.7%	-97.7%	-153.3%	-94.7%	-119.2%
EBITDA Margin	-22.0%	-27.1%	·	10.9%	-42.5%	-56.5%	·	-70.3%	-109.6%	-116.5%	·	-134.4%	-97.7%	-151.9%	-95.0%	-120.2%
ROA	-7.0%	-3.9%	·	1.8%	-4.7%	-5.3%	·	-5.0%	-6.9%	-6.7%	·	-6.3%	-6.1%	-7.0%	-4.8%	-5.7%
ROE	-24.7%	-9.8%	·	4.5%	-12.2%	-12.8%	·	-10.9%	-14.5%	-13.6%	·	-11.8%	-10.5%	-11.8%	-8.0%	-8.6%

Liquidità e Solvibilità 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Current Ratio	4.8	3.4	·	3.4	2.8	2.9	·	3.5	4.0	4.5	·	4.7	5.0	5.6	5.4	3.9
Quick Ratio	2.5	1.4	·	1.2	0.9	1.1	·	0.9	1.1	1.4	·	1.3	1.5	1.4	2.3	0.9
Debt / Equity	0.0	0.6	·	0.6	0.7	0.7	·	0.6	0.5	0.5	·	0.4	·	·	·	·
LT Debt / Equity	0.0	0.6	·	0.6	0.7	0.7	·	0.6	0.5	0.5	·	0.4	·	·	·	·
Interest Coverage	-5.9	-6.6	·	3.5	-8.5	-10.2	·	-11.1	-17.6	-16.3	·	-14.0	-13.3	-16.2	-69.6	·

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Asset Turnover	0.1	0.1	·	0.2	0.1	0.1	·	0.1	0.1	0.1	·	0.0	0.1	0.0	0.1	0.0
Inventory Turnover	2.1	1.9	·	1.7	1.7	1.5	·	1.1	1.2	1.1	·	1.1	0.9	0.9	0.8	0.7
Receivables Turnover	1.5	1.5	·	2.2	1.5	1.2	·	1.3	1.3	1.1	·	1.3	1.8	1.4	2.2	2.3

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Book Value / Share	$0.90	$1.35	·	$1.34	$1.18	$1.25	·	$1.52	$1.64	$1.87	·	$2.50	$2.74	$2.94	$3.41	$3.63
Revenue / Share	$0.45	$0.46	·	$0.58	$0.39	$0.35	·	$0.31	$0.29	$0.29	·	$0.26	$0.34	$0.26	$0.33	$0.31
Cash Flow / Share	·	$-0.06	·	·	·	$-0.19	·	·	·	$-0.26	·	·	·	$-0.41	·	·
Cash / Share	$1.07	$0.49	·	$0.36	$0.28	$0.33	·	$0.26	$0.41	$0.48	·	$0.61	$0.76	$0.66	$1.52	$0.54
EPS (TTM)	$-0.40	$-0.32	·	$-0.53	$-0.81	$-0.95	·	$-1.34	$-1.47	$-1.49	·	$-1.35	$-1.32	$-1.36	$-1.57	$-1.65

Valutazione (TTM) 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Revenue TTM	$308M	$295M	·	$253M	$205M	$190M	·	$177M	$169M	$175M	·	$180M	$190M	$184M	$168M	$160M
Net Income TTM	$-64M	$-50M	·	$-80M	$-121M	$-142M	·	$-195M	$-213M	$-215M	·	$-196M	$-191M	$-195M	$-221M	$-232M
Market Cap	$3.41B	$2.22B	·	$2.28B	$1.77B	$1.13B	·	$756M	$534M	$473M	·	$789M	$971M	$1.27B	$1.02B	$1.16B
Enterprise Value	$3.24B	$2.27B	·	$2.36B	$1.86B	$1.21B	·	$850M	$606M	$533M	·	$830M	·	·	·	·
P/E	-53.6	-43.4	·	-28.2	-14.4	-7.8	·	-3.8	-2.5	-2.2	·	-4.0	-5.1	-6.5	-4.5	-4.9
P/S	11.1	7.5	·	9.0	8.6	6.0	·	4.3	3.2	2.7	·	4.4	5.1	6.9	6.1	7.2
P/B	23.9	10.2	·	11.2	9.9	5.9	·	3.4	2.2	1.7	·	2.2	2.5	3.0	2.1	2.2
P / Tangible Book	148.0	23.1	·	27.4	30.5	16.5	·	7.5	4.5	3.1	·	3.3	3.6	4.3	2.8	2.9
P / Cash Flow	·	-232.4	·	·	·	-39.6	·	·	·	-12.3	·	·	·	-21.5	·	·
EV / Revenue	10.5	7.7	·	9.3	9.1	6.4	·	4.8	3.6	3.1	·	4.6	·	·	·	·
Earnings Yield	-1.9%	-2.3%	·	-3.5%	-7.0%	-12.8%	·	-26.2%	-40.6%	-46.4%	·	-24.8%	-19.7%	-15.4%	-22.1%	-20.4%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$277M	$179M	$170M	$185M	$154M
Margine Operativo %	-20.6%	-90.8%	-133.3%	-108.0%	-135.4%
Utile netto	$-59M	$-159M	$-225M	$-200M	$-207M
EPS Diluito	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.6	0.7	0.4	·	·
Rapporto corrente	3.3	2.9	4.7	5.1	3.5
Quick Ratio	1.3	0.9	1.2	1.2	1.4

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-49M	$-99M	$-167M	$-200M	$-254M

Proprietari istituzionali (13F) 312 filer · $3.5B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 312

Valore detenuto $3.5B

Nuove posizioni 46

Posizioni chiuse 37

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
46 (-11 vs trimestre precedente)	37 (0 vs trimestre precedente)	113 (+14 vs trimestre precedente)	85 (-12 vs trimestre precedente)	+17.2M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
VIKING GLOBAL INVESTORS LP	$643.365.037	29.993.708	18,50%	Azioni
BlackRock, Inc.	$324.734.962	15.139.159	9,34%	Azioni
VANGUARD GROUP INC	$183.222.148	11.282.152	5,27%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$137.356.941	6.403.587	3,95%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$126.798.802	5.911.366	3,65%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$117.465.155	5.476.231	3,38%	Azioni
D. E. Shaw & Co., Inc.	$99.224.675	4.625.859	2,85%	Azioni
WESTFIELD CAPITAL MANAGEMENT CO LP	$91.540.985	4.267.645	2,63%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$78.131.203	3.641.837	2,25%	Azioni
STATE STREET CORP	$74.181.636	3.458.388	2,13%	Azioni
Invesco Ltd.	$66.366.535	3.094.011	1,91%	Azioni
GOLDMAN SACHS GROUP INC	$64.011.670	2.984.227	1,84%	Azioni
UBS Group AG	$61.392.474	2.862.120	1,77%	Opzione Call
Driehaus Capital Management LLC	$54.219.229	2.527.703	1,56%	Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$54.153.099	2.524.620	1,56%	Azioni
Nuveen, LLC	$50.754.025	2.366.155	1,46%	Azioni
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$46.810.892	2.182.326	1,35%	Azioni
FRED ALGER MANAGEMENT, LLC	$44.879.492	2.092.284	1,29%	Azioni
ARK Investment Management LLC	$44.837.058	2.090.306	1,29%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$42.284.385	1.971.300	1,22%	Opzione Call
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$40.523.000	1.889.188	1,17%	Azioni
Aristotle Atlantic Partners, LLC	$39.436.104	1.838.513	1,13%	Azioni
TORONTO DOMINION BANK	$38.610.000	1.800.000	1,11%	Opzione Call
BANK OF AMERICA CORP /DE/	$37.109.444	1.730.044	1,07%	Azioni
JANE STREET GROUP, LLC	$34.116.504	1.590.513	0,98%	Azioni
NORTHERN TRUST CORP	$32.332.679	1.507.351	0,93%	Azioni
Sumitomo Mitsui Trust Group, Inc.	$28.525.411	1.329.856	0,82%	Azioni
Amova Asset Management Americas, Inc.	$28.512.113	1.329.856	0,82%	Azioni
OBERWEIS ASSET MANAGEMENT INC/	$27.000.209	1.258.751	0,78%	Azioni
PERCEPTIVE ADVISORS LLC	$26.111.621	1.217.325	0,75%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$25.279.940	1.178.552	0,73%	Azioni
AMERIPRISE FINANCIAL INC	$23.332.376	1.087.754	0,67%	Azioni
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$22.993.006	1.071.935	0,66%	Azioni
Blue Water Life Science Advisors, LP	$21.667.610	1.010.145	0,62%	Azioni
VANGUARD FIDUCIARY TRUST CO	$20.049.508	934.709	0,58%	Azioni
Aberdeen Group plc	$19.712.507	918.998	0,57%	Azioni
Freestone Grove Partners LP	$18.912.208	881.688	0,54%	Azioni
KENNEDY CAPITAL MANAGEMENT LLC	$18.228.103	849.795	0,52%	Azioni
Connor, Clark & Lunn Investment Management Ltd.	$16.857.619	785.903	0,48%	Azioni
PANAGORA ASSET MANAGEMENT INC	$16.679.842	777.615	0,48%	Azioni
MORGAN STANLEY	$16.435.667	766.230	0,47%	Azioni
Granite Investment Partners, LLC	$16.242.305	757.217	0,47%	Azioni
Trexquant Investment LP	$15.792.777	736.260	0,45%	Azioni
FMR LLC	$15.219.503	709.534	0,44%	Azioni
JENNISON ASSOCIATES LLC	$14.718.882	686.195	0,42%	Azioni
Hillsdale Investment Management Inc.	$14.676.454	684.217	0,42%	Azioni
NEXT CENTURY GROWTH INVESTORS LLC	$13.080.853	609.830	0,38%	Azioni
TUDOR INVESTMENT CORP ET AL	$11.657.753	543.485	0,34%	Azioni
ExodusPoint Capital Management, LP	$11.114.232	518.146	0,32%	Azioni
SEI INVESTMENTS CO	$10.935.157	509.797	0,31%	Azioni

Mostra tutti i 312 proprietari istituzionali →

Insider aziendali 27 insider · 17 dirigenti · 10 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Chad M Robins	CEO and Chairman	18 Agosto 2026 M	2.180.518	19	$-39.801.326
Kyle Piskel	Chief Financial Officer	18 Maggio 2026 S	256.725	6	$-3.581.681
Tycho Peterson	Chief Financial Officer	05 Marzo 2024 S	531.553	0	$0
Chad M Cohen	Chief Financial Officer	22 Dicembre 2021 M	21.604	0	$0
Julie Rubinstein	President and COO	27 Aprile 2026 M	377.802	47	$-13.371.115
Mark R Adams	Chief Operating Officer	11 Aprile 2023 S	175.361	0	$0
Francis Lo	Chief People Officer	16 Settembre 2026 M	220.867	15	$-13.213.683
Susan Bobulsky	Chief Commercial Officer, MRD	15 Settembre 2026 S	395.794	9	$-1.204.076
Harlan S Robins	Chief Scientific Officer	21 Luglio 2026 M	812.058	17	$-29.647.952
Sharon Benzeno	Chief Commercial Ofc Imm Med	29 Giugno 2026 M	221.278	6	$-14.690.980
Stacy L Taylor	SVP and General Counsel	22 Agosto 2024 S	139.365	0	$0
Nitin Sood	Chief Commercial Officer, MRD	08 Agosto 2023 S	214.808	0	$0
Lance Baldo	Chief Medical Officer	08 Marzo 2022 S	17.171	0	$0
Jyoti Palaniappan	SVP, Diagnostics, T-Detect	19 Luglio 2021 M	9.158	0	$0
Henning Thorsen	SVP, Commercial Operations	17 Maggio 2021 A	29.061	0	$0
Nancy Louise Hill	EVP, Operations & Program Mana	19 Gennaio 2021 M	10.000	0	$0
Charles Sang	SVP, External Affairs	11 Dicembre 2020 M	0	0	$0
Katey Einterz Owen	Direttore	31 Agosto 2026 G	66.100	1	$-249.990
Robert Hershberg	Direttore	18 Agosto 2026 M	46.683	3	$-1.115.696
Peter M Neupert	Direttore	17 Agosto 2026 M	130.625	3	$-3.135.850
Michelle Renee Griffin	Direttore	25 Giugno 2026 M	15.625	3	$-2.000.259
Michael J Pellini	Direttore	04 Marzo 2025 A	69.690	0	$0
Kevin T Conroy	Direttore	06 Marzo 2023 A	22.968	0	$0
Leslie Trigg	Direttore	06 Marzo 2023 A	25.907	0	$0
David E. Goel	Direttore	15 Febbraio 2021 A	1.504	0	$0
Andris A Zoltners	Direttore	13 Febbraio 2020 A	3.621.016	0	$0
Eric Dobmeier	·	14 Febbraio 2021 A	1.504	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 35 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
ARKG · ARK ETF Trust	2,57%	1.774.756 NS	31 Luglio 2026	N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST	2,11%	64.619 NS	31 Luglio 2026	N-PORT
DWAS · Invesco Exchange-Traded Fund Trust …	1,26%	186.189 SH	02 Ottobre 2026	Giornaliero
MEDI · Harbor ETF Trust	0,98%	17.855 NS	31 Luglio 2026	N-PORT
BRNY · EA Series Trust	0,57%	147.197 NS	31 Luglio 2026	N-PORT
FYC · First Trust Exchange-Traded AlphaDE…	0,57%	327.285 NS	31 Luglio 2026	N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust …	0,29%	11.293 SH	02 Ottobre 2026	Giornaliero
IBB · iShares Trust	0,28%	1.179.205 SH	11 Settembre 2026	Giornaliero
FYX · First Trust Exchange-Traded AlphaDE…	0,27%	162.673 NS	31 Luglio 2026	N-PORT
IWO · iShares Trust	0,24%	1.444.121 SH	11 Settembre 2026	Giornaliero
ESSC · Strategy Shares	0,24%	3.763 NS	31 Luglio 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0,19%	165.252 SH	19 Agosto 2026	Giornaliero
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,14%	42.053 NS	31 Luglio 2026	N-PORT
ISCG · iShares Trust	0,12%	49.206 SH	11 Settembre 2026	Giornaliero
IWM · iShares Trust	0,12%	3.941.006 SH	11 Settembre 2026	Giornaliero
FAD · First Trust Exchange-Traded AlphaDE…	0,12%	29.650 NS	31 Luglio 2026	N-PORT
RSSL · Global X Funds	0,11%	73.784 NS	31 Luglio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,10%	886.884 SH	19 Agosto 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,09%	85.150 SH	02 Ottobre 2026	Giornaliero
ESML · iShares Trust	0,06%	69.841 SH	11 Settembre 2026	Giornaliero
VFMO · VANGUARD WELLINGTON FUND	0,06%	51.690 SH	19 Agosto 2026	Giornaliero
VBK · VANGUARD INDEX FUNDS	0,04%	1.011.327 SH	19 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,04%	345.932 SH	19 Agosto 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,04%	55.701 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,03%	1.415.247 SH	19 Agosto 2026	Giornaliero
WSML · iShares Trust	0,03%	7.584 SH	11 Settembre 2026	Giornaliero
VB · VANGUARD INDEX FUNDS	0,02%	1.746.783 SH	19 Agosto 2026	Giornaliero
OMFS · Invesco Exchange-Traded Self-Indexe…	0,01%	1.197 SH	02 Ottobre 2026	Giornaliero
TILT · FlexShares Trust	0,01%	9.559 NS	31 Luglio 2026	N-PORT
IWV · iShares Trust	0,01%	43.739 SH	10 Settembre 2026	Giornaliero
ITOT · iShares Trust	0,00%	170.690 SH	11 Settembre 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	4.835.465 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	12.307 SH	19 Agosto 2026	Giornaliero
ISCB · iShares Trust	·	6.963 SH	11 Settembre 2026	Giornaliero
SMLF · iShares Trust	·	172.353 SH	11 Settembre 2026	Giornaliero

ADPT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 14 analisti COMPRA

Target mediano $27.25 -3,9%

5 35,7% Acquisto forte

7 50,0% Compra

2 14,3% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

8 analisti · 2026-09-30

Target medio $27.44 -3,2%

Ora Prezzo attuale $28.35

Basso$21.00 Media$27.44 Alto$35.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	·
AVTR	$7.82B	-14.7	-3.4%	-8.1%	-8.9%	32.6%
RGEN	$9.23B	190.5	16.4%	6.6%	2.4%	·
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
BIO	·	·	·	·	·	·
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
ALMR	·	·	·	·	·	·
MRVI	·	-3.6	-28.3%	-70.4%	-48.6%	18.3%
FTRE	$1.61B	-1.6	1.0%	-36.2%	-171.1%	·
BLFS	·	-241.8	28.9%	·	·	·

Ultime notizie Notizie recenti che menzionano questa società

23

Adaptive Biotech (ADPT) Reports 35% Revenue Growth Driven by Strong clonoSEQ Performance in Q1 2026 Yahoo Finance · 3 mesi, 4 settimane fa Il Chief Operating Officer di Adaptive Biotechnologies ha venduto oltre 19.000 azioni della società. Ecco cosa significa per gli investitori. Nasdaq · 4 mesi, 4 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

ADPT Adaptive Biotechnologies Corporation - Common Stock